S&P 500   3,348.48 (+1.52%)
DOW   27,661.63 (+1.79%)
QQQ   275.21 (+1.34%)
AAPL   113.41 (+1.01%)
MSFT   209.51 (+0.81%)
FB   256.61 (+0.70%)
GOOGL   1,456.25 (+1.19%)
AMZN   3,146.69 (+1.67%)
TSLA   420.59 (+3.25%)
NVDA   515.22 (+0.05%)
BABA   276.05 (+1.83%)
CGC   14.37 (+1.41%)
GE   6.26 (+2.45%)
MU   49.57 (+0.88%)
AMD   78.94 (+1.13%)
T   28.47 (+1.53%)
F   6.69 (+2.76%)
ACB   4.86 (-3.76%)
GILD   62.70 (+0.72%)
NFLX   482.07 (-0.17%)
DIS   126.21 (+1.78%)
BA   165.91 (+6.33%)
BAC   24.13 (+2.72%)
S&P 500   3,348.48 (+1.52%)
DOW   27,661.63 (+1.79%)
QQQ   275.21 (+1.34%)
AAPL   113.41 (+1.01%)
MSFT   209.51 (+0.81%)
FB   256.61 (+0.70%)
GOOGL   1,456.25 (+1.19%)
AMZN   3,146.69 (+1.67%)
TSLA   420.59 (+3.25%)
NVDA   515.22 (+0.05%)
BABA   276.05 (+1.83%)
CGC   14.37 (+1.41%)
GE   6.26 (+2.45%)
MU   49.57 (+0.88%)
AMD   78.94 (+1.13%)
T   28.47 (+1.53%)
F   6.69 (+2.76%)
ACB   4.86 (-3.76%)
GILD   62.70 (+0.72%)
NFLX   482.07 (-0.17%)
DIS   126.21 (+1.78%)
BA   165.91 (+6.33%)
BAC   24.13 (+2.72%)
S&P 500   3,348.48 (+1.52%)
DOW   27,661.63 (+1.79%)
QQQ   275.21 (+1.34%)
AAPL   113.41 (+1.01%)
MSFT   209.51 (+0.81%)
FB   256.61 (+0.70%)
GOOGL   1,456.25 (+1.19%)
AMZN   3,146.69 (+1.67%)
TSLA   420.59 (+3.25%)
NVDA   515.22 (+0.05%)
BABA   276.05 (+1.83%)
CGC   14.37 (+1.41%)
GE   6.26 (+2.45%)
MU   49.57 (+0.88%)
AMD   78.94 (+1.13%)
T   28.47 (+1.53%)
F   6.69 (+2.76%)
ACB   4.86 (-3.76%)
GILD   62.70 (+0.72%)
NFLX   482.07 (-0.17%)
DIS   126.21 (+1.78%)
BA   165.91 (+6.33%)
BAC   24.13 (+2.72%)
S&P 500   3,348.48 (+1.52%)
DOW   27,661.63 (+1.79%)
QQQ   275.21 (+1.34%)
AAPL   113.41 (+1.01%)
MSFT   209.51 (+0.81%)
FB   256.61 (+0.70%)
GOOGL   1,456.25 (+1.19%)
AMZN   3,146.69 (+1.67%)
TSLA   420.59 (+3.25%)
NVDA   515.22 (+0.05%)
BABA   276.05 (+1.83%)
CGC   14.37 (+1.41%)
GE   6.26 (+2.45%)
MU   49.57 (+0.88%)
AMD   78.94 (+1.13%)
T   28.47 (+1.53%)
F   6.69 (+2.76%)
ACB   4.86 (-3.76%)
GILD   62.70 (+0.72%)
NFLX   482.07 (-0.17%)
DIS   126.21 (+1.78%)
BA   165.91 (+6.33%)
BAC   24.13 (+2.72%)
Log in
OTCMKTS:ABCZY

ABCAM PLC/ADR Stock Forecast, Price & News

$15.85
+0.15 (+0.96 %)
(As of 09/25/2020 08:10 PM ET)
Add
Compare
Today's Range
$15.39
Now: $15.85
$15.98
50-Day Range
$14.56
MA: $16.98
$18.06
52-Week Range
$11.26
Now: $15.85
$19.73
Volume2,666 shs
Average Volume4,266 shs
Market Capitalization$3.25 billion
P/E Ratio37.74
Dividend Yield0.44%
Beta1.29
Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also sells its products online. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.
Read More
ABCAM PLC/ADR logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.98 out of 5 stars


Industry, Sector and Symbol

Industry Industrial inorganic chemicals, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ABCZY
Previous SymbolNASDAQ:ABCZY
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$336.37 million

Profitability

Miscellaneous

Employees1,100
Market Cap$3.25 billion
Next Earnings Date10/2/2020 (Estimated)
OptionableNot Optionable
$15.85
+0.15 (+0.96 %)
(As of 09/25/2020 08:10 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ABCZY News and Ratings via Email

Sign-up to receive the latest news and ratings for ABCZY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ABCAM PLC/ADR (OTCMKTS:ABCZY) Frequently Asked Questions

How has ABCAM PLC/ADR's stock been impacted by Coronavirus (COVID-19)?

ABCAM PLC/ADR's stock was trading at $14.83 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABCZY stock has increased by 6.9% and is now trading at $15.85.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of ABCAM PLC/ADR?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ABCAM PLC/ADR in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for ABCAM PLC/ADR
.

When is ABCAM PLC/ADR's next earnings date?

ABCAM PLC/ADR is scheduled to release its next quarterly earnings announcement on Friday, October 2nd 2020.
View our earnings forecast for ABCAM PLC/ADR
.

How often does ABCAM PLC/ADR pay dividends? What is the dividend yield for ABCAM PLC/ADR?

ABCAM PLC/ADR declared a Semi-Annual dividend on Tuesday, March 10th. Shareholders of record on Friday, March 20th will be paid a dividend of $0.037 per share on Friday, May 1st. The ex-dividend date of this dividend is Thursday, March 19th.
View ABCAM PLC/ADR's dividend history
.

Are investors shorting ABCAM PLC/ADR?

ABCAM PLC/ADR saw a decrease in short interest during the month of September. As of September 15th, there was short interest totaling 4,400 shares, a decrease of 26.7% from the August 31st total of 6,000 shares. Based on an average trading volume of 9,600 shares, the days-to-cover ratio is currently 0.5 days.
View ABCAM PLC/ADR's Short Interest
.

Who are some of ABCAM PLC/ADR's key competitors?

Who are ABCAM PLC/ADR's key executives?

ABCAM PLC/ADR's management team includes the following people:
  • Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 51)
  • Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 54)
  • Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 49)
  • James Staveley, VP of Investor Relations
  • Mr. Nick Skinner, Sr. VP of HR

What is ABCAM PLC/ADR's stock symbol?

ABCAM PLC/ADR trades on the OTCMKTS under the ticker symbol "ABCZY."

How do I buy shares of ABCAM PLC/ADR?

Shares of ABCZY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ABCAM PLC/ADR's stock price today?

One share of ABCZY stock can currently be purchased for approximately $15.85.

How big of a company is ABCAM PLC/ADR?

ABCAM PLC/ADR has a market capitalization of $3.25 billion and generates $336.37 million in revenue each year. ABCAM PLC/ADR employs 1,100 workers across the globe.

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.